Cervical cancer
Conditions
Interventions
Case group (Intratumoral microecological community):None
Control group (Microecological community):None
Sponsors
Chongqing Health Center for Women and Children
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Patients with gynecological malignant tumors: Patients who have been diagnosed with gynecological malignant tumors by histopathological examination; are at least 18 years old; have an expected survival period of = 3 months; have understood the entire study, signed the informed consent form, and voluntarily enrolled in the study. 2.Patients with benign gynecological tumors: Patients who have been diagnosed with benign gynecological tumors by histopathological examination; are at least 18 years old; have understood the entire study, signed the informed consent form, and voluntarily joined the group. 3.Health check-up participants: volunteers who are at least 18 years old; have no digestive system symptoms such as constipation or diarrhea within the recent 3 months; have understood the entire study, signed the informed consent form, and voluntarily joined the group.
Exclusion criteria
Exclusion criteria: 1.Patients with gynecological malignant tumors: those with other concurrent malignant tumor diseases; those with inflammatory bowel disease or other immune diseases; those with severe dysfunction of important organs such as the heart, liver, and kidneys; those who have used antibiotics, probiotics, or other drugs that may affect the microecology within the past month; those with mental illness or cognitive impairment who cannot cooperate in completing the study; those who refuse to participate in this study or fail to cooperate with follow-up. 2.Patients with benign gynecological tumors: those with comorbid inflammatory bowel disease or other immune diseases; those with severe dysfunction of important organs such as the heart, liver, and kidneys; those who have used antibiotics, probiotics, or other drugs that may affect the microecology within the past month; those with mental illness or cognitive impairment who cannot cooperate in completing the study; those who refuse to participate in this study or do not cooperate with follow-up. 3.Health check-up participants: those with comorbid inflammatory bowel disease or other immune diseases; those with other digestive system diseases; those with a history of digestive system surgery; those who have used antibiotics, probiotics, or other drugs that may affect the microecology within the past month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Differences in intratumoral microecological diversity between cancerous tissue and adjacent tissue; | — |
Secondary
| Measure | Time frame |
|---|---|
| External control differences;Clinicopathological correlation;Differences in microecological composition;patients' prognostic; | — |
Countries
China
Contacts
Public ContactChengzhi Zhao
Chongqing Health Center for Women and Children
Outcome results
None listed